Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
CHRS
CHRS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CHRS News
Coherus Oncology Q4 2025 Earnings Call Highlights
19h ago
seekingalpha
Coherus Oncology Reports Strong 2025 Financial Results
17h ago
Yahoo Finance
Coherus BioSciences Reports Q4 Earnings Miss
23h ago
seekingalpha
Coherus BioSciences to Announce Q4 Earnings on March 9
1d ago
seekingalpha
Coherus Oncology to Release 2025 Financial Results on March 9, 2026
Mar 02 2026
Newsfilter
Coherus Oncology to Present at Upcoming Conferences
Feb 23 2026
Newsfilter
Coherus Oncology Prices $50.1 Million Public Offering
Feb 13 2026
NASDAQ.COM
Applied Materials Reports Strong Q1 Results, Shares Surge
Feb 13 2026
Benzinga
Coherus Oncology Prices Public Offering at $1.75 per Share
Feb 13 2026
seekingalpha
Coherus Oncology Prices Public Offering at $1.75 per Share
Feb 13 2026
Newsfilter
Johnson & Johnson Partners with Coherus for Cancer Trial
Feb 04 2026
seekingalpha
Oncolytics Biotech Strengthens Leadership Amid Oncology Market Surge
Jan 27 2026
Newsfilter
Oncolytics Biotech Strengthens Leadership for Oncology Trials
Jan 27 2026
PRnewswire
Oppenheimer Initiates Coherus Oncology (CHRS) at Outperform with $10 Price Target
Jan 23 2026
seekingalpha
Biotech Stocks Surge: Coherus Up 9.09% in After-Hours Trading
Jan 23 2026
NASDAQ.COM
GT Biopharma Submits IND for GTB-5550 Targeting $362 Billion Solid Tumor Market
Jan 16 2026
PRnewswire
Show More News
